1. Home
  2. NVNO vs CODA Comparison

NVNO vs CODA Comparison

Compare NVNO & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNO
  • CODA
  • Stock Information
  • Founded
  • NVNO 1987
  • CODA 1994
  • Country
  • NVNO United States
  • CODA United States
  • Employees
  • NVNO N/A
  • CODA N/A
  • Industry
  • NVNO Medical/Dental Instruments
  • CODA Industrial Machinery/Components
  • Sector
  • NVNO Health Care
  • CODA Industrials
  • Exchange
  • NVNO Nasdaq
  • CODA Nasdaq
  • Market Cap
  • NVNO 96.0M
  • CODA 83.5M
  • IPO Year
  • NVNO N/A
  • CODA N/A
  • Fundamental
  • Price
  • NVNO $4.91
  • CODA $7.73
  • Analyst Decision
  • NVNO
  • CODA Strong Buy
  • Analyst Count
  • NVNO 0
  • CODA 1
  • Target Price
  • NVNO N/A
  • CODA $11.00
  • AVG Volume (30 Days)
  • NVNO 136.6K
  • CODA 53.9K
  • Earning Date
  • NVNO 07-31-2025
  • CODA 09-15-2025
  • Dividend Yield
  • NVNO N/A
  • CODA N/A
  • EPS Growth
  • NVNO N/A
  • CODA 21.86
  • EPS
  • NVNO N/A
  • CODA 0.30
  • Revenue
  • NVNO N/A
  • CODA $22,758,966.00
  • Revenue This Year
  • NVNO N/A
  • CODA $30.82
  • Revenue Next Year
  • NVNO N/A
  • CODA $20.84
  • P/E Ratio
  • NVNO N/A
  • CODA $25.76
  • Revenue Growth
  • NVNO N/A
  • CODA 24.78
  • 52 Week Low
  • NVNO $2.03
  • CODA $5.76
  • 52 Week High
  • NVNO $5.70
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • NVNO 56.87
  • CODA 51.59
  • Support Level
  • NVNO $4.33
  • CODA $7.30
  • Resistance Level
  • NVNO $5.13
  • CODA $7.70
  • Average True Range (ATR)
  • NVNO 0.35
  • CODA 0.36
  • MACD
  • NVNO -0.05
  • CODA 0.02
  • Stochastic Oscillator
  • NVNO 62.50
  • CODA 71.28

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

Share on Social Networks: